LOS ANGELES, CA (August 10, 2006) - DoveBid, Inc., (http://www.dovebid.com), the global leader in capital asset auction and valuation services, announced today it will be conducting its 50th global Life Sciences / BioPharma Exchange auction online, on August 15, 2006. The event marks a milestone for the DoveBid.com Life Sciences / BioPharma practice, and is expected to bring to-date total assets sold to over US$1 billion in original acquisition costs. Since the Life Sciences Industry Practice inception in 2003, DoveBid has dedicated global resources to bring best-in-class solutions to market supporting life science, pharmaceutical and healthcare industries.
The DoveBid Life Sciences / BioPharma Exchange enables organizations to proactively address asset management challenges in real time. DoveBid clients consign equipment from global locations and draw from DoveBid's portfolio of dedicated Marketing and Valuation solutions in order to bring the right buyers to the right assets at the right time. Global leaders participating in this program include Pfizer (NYSE:PFE), Bristol-Myers Squibb (NYSE:BMY), Procter & Gamble (NYSE:PG), Schering Corporation (NYSE:SGP), and mid-market competitors. "DoveBid's online Life Sciences marketplace and dedicated marketing deliver higher returns on surplus assets.
They understand our business, asset valuations and the global market for Life Sciences and Pharma equipment. We're seeing very positive results in asset disposition, redeployment and overall execution," said William Carr, Director of Global Sourcing for Pfizer Global R&D, Pfizer.
DoveBid offers both Self-service and Full-service, allowing global organ